ArticleMolecular medicine (Cambridge, Mass.)2025

Tousled-like kinase loss confers PARP inhibitor resistance in BRCA1-mutated cancers by impeding non-homologous end joining repair.

Min-Ah Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.